FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20250425E00464
1. Date of relevant event: 22/04/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02186
4. Name of listed corporation: Luye Pharma Group Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 3,761,670,643
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Liu
(Other names) Dianbo
10. Name of director (Chinese): 刘殿波 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1203The number of shares in which you are interested has reduced because:
you delivered the shares or an amount due under equity derivatives
 
2301Trustee
 
2301Trustee
 		 17,088,000         
 
Short position 
15012You ceased to have a short position in the shares or the number of shares in which you have a short position decreased because:
expiry or cancellation without exercise of equity derivatives under which (choose one):
you are under an obligation to deliver the underlying shares
 
2301Trustee
 
2301Trustee
 		 17,088,000           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position1,261,196,70333.53
Short position229,317,9506.10
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position1,244,108,70333.07
Short position212,229,9505.64
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2301Trustee
Long position1,244,108,703
Short position212,229,950
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Short position
4105Unlisted derivatives - Physically settled
        212,229,950
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Shorea LBGHelvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey)Liu Dianbo100.00N
Long position1,244,108,703
Short position212,229,950
Ginkgo (PTC) LimitedHelvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey)Shorea LBG100.00N
Long position1,244,108,703
Short position212,229,950
Nelumbo Investments LimitedHelvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey)Ginkgo (PTC) Limited100.00N
Long position1,244,108,703
Short position212,229,950
Luye Life Sciences Group LtdClarendon House, 2 Church Street, Hamilton HM 11, Bermuda (Bermuda)Nelumbo Investments Limited70.00N
Long position1,244,108,703
Short position212,229,950
Luye Pharma Holdings Ltd.Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands (Cayman Islands)Luye Life Sciences Group Ltd100.00N
Long position1,244,108,703
Short position212,229,950
LuYe Pharmaceutical International Co., Ltd.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Luye Pharma Holdings Ltd.100.00N
Long position1,244,108,703
Short position212,229,950
LuYe Pharmaceutical Investment Co., Ltd.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)LuYe Pharmaceutical International Co., Ltd.100.00Y
Long position1,244,108,703
Short position212,229,950
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information:
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 25/04/2025
(dd/mm/yyyy)